Wikisage, the free encyclopedia of the second generation, is digital heritage

Epilepsy: Difference between revisions

From Wikisage
Jump to navigation Jump to search
mNo edit summary
(thumbºleftº)
Line 10: Line 10:


nonadherence appears to be associated with increased health care costs, nevertheless XR-medicine appears as strategy to overcome compliance wih [[antiepileptic drug|AED]]<ref>(Davis et al 2008)</ref>
nonadherence appears to be associated with increased health care costs, nevertheless XR-medicine appears as strategy to overcome compliance wih [[antiepileptic drug|AED]]<ref>(Davis et al 2008)</ref>
 
[[File: 1Eslicarbazepine structure.svg.png acetato|thumb|left|escarbazepine]]
{| class="toccolours float-right taxobox pilze"  style="font-size:80%;" cellpadding="3" cellspacing="3"
{| class="toccolours float-right taxobox pilze"  style="font-size:80%;" cellpadding="3" cellspacing="3"
| colspan="3" background-color:#000000;" |  
| colspan="3" background-color:#000000;" |  

Revision as of 18:29, 3 August 2015

Classification of ethiology could divided in four categories:

  • idiopathic epilepsy
  • symptomatic epilepsy
  • provoked epilepsy
  • cryptogenic epilepsy

[1] It is difficult to distinguish between genetic and cryptogenic syndromes.

Morbility data is difficult to interpret when WHO[2] states 50-70 millions persons[3] suffers epilepsy[4]

nonadherence appears to be associated with increased health care costs, nevertheless XR-medicine appears as strategy to overcome compliance wih AED[5]

File:1Eslicarbazepine structure.svg.png acetato
escarbazepine

Medicines

type  ,,, ,,,,
INN  Generic slow release
carbamazepine  normal xr
lamotrigine  normal xr
levetiracetam  normal xr
oxcarbazepine  ... xr
phenitoin  ... xr
valproate  xr
topiramate  xr

AED

A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures

A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures

In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein

ILAE Classification

[6] [7] [8] [9] ILAE Overview

See also

A new perspective for Epileptic Disorders

Links

Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population

The Efficacy of Leviteracetam versus Carbamazepine for Epilepsy: A Meta-Analysis

The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs

Lennox-Gastaut Syndrome

Dravet's syndrome

Status epilepticus

References

References:
  1. ↑ The etiologic classification of epilepsy
  2. ↑ http://www.who.int/en/
  3. ↑ (Li et al 2014)
  4. ↑ (Chung 2015)
  5. ↑ (Davis et al 2008)
  6. ↑ http://www.who.int/mediacentre/factsheets/fs999/en/
  7. ↑ epilepsy is not resolved. Epilepsy Currents 14 2014
  8. ↑ https://www.ligaepilepsia.cl/epilepsias/tipos-de-epilepsia
  9. ↑ Annie T Berg et al.2010 Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009 Epilepsia 51 676-685
Retrieved from "http://en.wikisage.org/w/index.php?title=Epilepsy&oldid=1576"